Tasmanian medical research charity funds projects that have a global impact and improve community health and well-being.
- Tasmanian medical research charity funds projects that support community health and well-being, with clinicians and researchers working across the health system and university.
- Tasmanian medical research on childhood cataracts and gene variants can be easily studied and applied globally due to the small population and genetic diversity of the island state.
- The Royal Hobart Hospital Research Foundation funds medical research in various fields to support the Tasmanian community, in areas such as cardiothoracic, neurological conditions, and premature babies.
- Research supported by RHHRF has led to the development of innovative treatments for JackJumper ant bites, resulting in the establishment of a desensitisation clinic at the hospital and a significant reduction in deaths from anaphylactic shocks caused by these bites.
- Tasmanian medical research has had a global impact, with projects like the Hobart Method being implemented in neonatal clinics worldwide, and blood pressure testing research involving patients from Tasmania, China, Italy, and other countries.
Australian Health Journal spoke to Stephanie Furler the Chief Executive Officer of The Royal Hobart Hospital Research Foundation about the impact of this research locally and in global health.
-
Expansion of specialist training in regional & rural areas
Associate Professor Sanjay Jeganathan, Chair of the Council of Presidents of Medical Colleges (CPMC) states, ”Our rural and regional communities deserve the same access to specialist care as our cities. We’re seeing real results from our colleges’ commitment to rural training.”
-
Australian Healthcare Week
Held 27th-28th March at the ICC Sydney, the expo is one of the largest, if not the largest healthcare events in the regions. AHJ as media partner attended and met with delegates, exhibitors and leaders in the healthcare industry. Click the post to see footage.
-
Cardinal Health brings device reprocessing plant to Australia
Cardinal Health is global medical products manufacturer and leading provider of single-use device reprocessing services in the U.S. In Australia and New Zealand, as one of the largest suppliers of medical devices, announced on 23 May 2024 that it will be opening a single-use medical device reprocessing facility in Australia – its first reprocessing facility outside the United States.
On 18 March 2025 at the Health Innovation Living Lab at the John Hunter Hospital, a further announcement was made, on the chosen single-use medical device remanufacturing facility in Beresfield, Newcastle, set to commence operation late 2025, supported by the NSW Department of Primary Industries and Regional Development.
